Genmab A GMAB
NASDAQ GMAB
$39.36 +0.29 (+0.74%)
As of: Oct 21, 2026 · 1:28 PM EDT

Genmab A (GMAB) Tax Rate (2024 - 2025)

Updated

Genmab A (GMAB) recorded Tax Rate of -2.71% in the quarter ended Jun 30, 2026.

Analysis

Genmab A (GMAB) Tax Rate (2024 - 2025) Analysis & Trends

On a TTM basis, Genmab A's Tax Rate came in at 81.81% as of Jun 30, 2026; for the year ended Dec 31, 2025, it was 20.02%, up 5.46 percentage points from the prior year.

  • Annual Tax Rate has a three-year change of -160.96 percentage points (years ended Dec 2022 to Dec 2025).
  • Across earlier years, Tax Rate came in at 14.56% in the year ended Dec 31, 2024 (-8.21 pp), 22.77% in the year ended Dec 31, 2023 (-158.21 pp) and 180.98% in the year ended Dec 31, 2022.
  • The figure for the quarter ended Jun 30, 2026 is the highest quarterly Tax Rate since the quarter ended Jun 30, 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Eli Lilly 1,134.69 Bn 1,103.27 Bn 19.71 Bn 23.27%
2 Johnson & Johnson 616.29 Bn 534.82 Bn 17.26 Bn 17.98%
3 AbbVie 500.86 Bn 473.97 Bn 12.70 Bn 15.47%
4 Merck 366.77 Bn 321.15 Bn 12.21 Bn -
5 Novartis Ag 297.69 Bn 261.68 Bn 11.24 Bn 23.71%
6 Astrazeneca 261.39 Bn 235.08 Bn 12.86 Bn 10.40%
7 Amgen 235.52 Bn 190.92 Bn 7.24 Bn 14.20%
8 Gilead Sciences 190.49 Bn 164.69 Bn 6.22 Bn -
9 Pfizer 169.46 Bn 116.11 Bn 10.94 Bn -
10 Genmab A 2.55 Bn -2.83 Bn 1.07 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 20.57%
Jun 30, 2024 33.88%
API Access

Genmab A Tax Rate API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-rate&ticker=GMAB&period=max&api_key=YOUR_API_KEY